Moreover, we observed a significant positive correlation between HMGA2 and HMGA2-AS1 expression in TCGA (The Cancer Genome Atlas) data derived from breast invasive carcinoma, colon adenocarcinoma, liver hepatocellular carcinoma, pancreatic adenocarcinoma, prostate adenocarcinoma, and thyroid carcinoma patient datasets (Figure 3C). Here, HMGA2 is linked to prostate adenocarcinoma.